Concomitant chemoradiotherapy for advanced squamous cell carcinoma of the temporal bone
Head & Neck2015Vol. 38(S1), pp. E949–53
Citations Over TimeTop 19% of 2015 papers
Hirotaka Shinomiya, Shingo Hasegawa, Daisuke Yamashita, Yasuo Ejima, Kenji Yoshida, Naoki Otsuki, Naomi Kiyota, Shunsuke Sakakibara, Tadashi Nomura, Kazunobu Hashikawa, Eiji Kohmura, Ryohei Sasaki, Ken‐ichi Nibu
Abstract
The results of our study indicate that CCRT with TPF for locally advanced temporal bone cancer is an effective and promising regimen. © 2015 Wiley Periodicals, Inc. Head Neck 38: E949-E953, 2016.
Related Papers
- Gastric cancer in the province of Zaragoza (Spain): a survival study.(1996)
- → Weight Loss as a Nutritional Indicator in Head and Neck Cancer Patients Undergoing Chemoradiotherapy: Contributing Factors and Its Impact on Disease Outcome(2020)5 cited
- → Head-neck cancer under concurrent chemoradiotherapy: does weight loss affect disease progression and treatment efficacy?(2020)1 cited
- Analysis of the Survival Rate for Young Patients with Breast Cancer(2008)
- → Buried Bumper Syndrome: a rare complication during radical chemoradiotherapy for head and neck cancer(2021)